Waters公司以17.5B美元购买BD的生物科学和诊断,将其市场翻一番,达到40B美元。 Waters Corporation buys BD's Biosciences & Diagnostics for $17.5B, doubling its market to $40B.

Waters Corporation将获得BD的生物科学与诊断解决方案公司175亿美元的交易,其结构是税收效率高的反向莫里斯信托公司。 Waters Corporation will acquire BD's Biosciences & Diagnostic Solutions business in a $17.5 billion deal, structured as a tax-efficient Reverse Morris Trust. 预计这一合并将使Waters的可处理市场总额翻一番,达到400亿美元,到2030年将产生巨大的成本和收入协同效应。 This merger is expected to double Waters' total addressable market to $40 billion and create significant cost and revenue synergies by 2030. 交易定于2026年第一季度结束时结束。 The transaction is set to close by the end of the first quarter 2026.